Evidence map›Paper›PMID 36322149›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2023

Biallelic variants in PIGN cause Fryns syndrome, multiple congenital anomalies-hypotonia-seizures syndrome, and neurologic phenotypes: A genotype-phenotype correlation study.

Lucy Loong, Agostina Tardivo, Alexej Knaus, Mona Hashim, Alistair T Pagnamenta, Kerstin Alt, Helena Böhrer-Rabel, Alfonso Caro-Llopis, Trevor Cole, Felix Distelmaier and 34 more

Open access · greenAbstract read
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. In-Depth Phenotyping ofBiomolecules · 2024
    Article
  4. Review
  5. Article
  6. Heliyon · 2024
    Article
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

44 authors at 20 institutions in 10 countries.

Lucy LoongOxford Centre for Genomic Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
Agostina TardivoNational Center of Medical Genetics, National Administration of Health Laboratories and Institutes, National Ministry of Health, Buenos Aires, Argentina.
Alexej KnausInstitute for Genomic Statistics and Bioinformatics, University Hospital Bonn, Rheinische Friedrich-Wilhelms-University Bonn, Bonn, Germany.
Mona HashimNIHR Oxford Biomedical Research Centre, Wellcome Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.
Alistair T PagnamentaNIHR Oxford Biomedical Research Centre, Wellcome Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.
Kerstin AltGenetikum, Center for Human Genetics, Neu-Ulm, Germany.
Helena Böhrer-RabelGenetikum, Center for Human Genetics, Neu-Ulm, Germany.
Alfonso Caro-LlopisUnidad de Genética, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
Trevor ColeWest Midlands Clinical Genetics Unit, Birmingham Women's and Children's NHS FT and Birmingham Health Partners, Birmingham, United Kingdom.
Felix DistelmaierDepartment of General Pediatrics, Neonatology and Pediatric Cardiology, University Children's Hospital, Heinrich-Heine-University, Düsseldorf, Germany.
Patrick EderyDepartment of Medical Genetics, Lyon University Hospital, Lyon, France.
Carlos R FerreiraNational Human Genome Research Institute, National Institutes of Health, Bethesda, MD.
Aleksandra Jezela-StanekDepartment of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, Poland.
Bronwyn KerrManchester Centre for Genomic Medicine, St Mary's Hospital, Manchester, United Kingdom.
Gerhard KlugerGenetikum, Center for Human Genetics, Neu-Ulm, Germany.
Peter M KrawitzInstitute for Genomic Statistics and Bioinformatics, University Hospital Bonn, Rheinische Friedrich-Wilhelms-University Bonn, Bonn, Germany.
Marius KuhnGenetikum, Center for Human Genetics, Neu-Ulm, Germany.
Johannes R LemkeInstitute of Human Genetics, University of Leipzig Medical Center, Leipzig, Germany.
Gaetan LescaDepartment of Medical Genetics, Lyon University Hospital, Lyon, France.
Sally Ann LynchDepartment of Clinical Genetics, Children's Health Ireland (CHI) at Crumlin, Dublin, Ireland.
Francisco MartinezUnidad de Genética, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
Caroline MaxtonPraxis für Neuropädiatrie, Hamburg, Germany.
Hanna MierzewskaClinic of Pediatric Neurology, Institute of Mother and Child, Warsaw, Poland.
Sandra MonfortUnidad de Genética, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
Joost NicolaiDepartment of Neurology, Maastricht University Medical Centre, Maastricht, The Netherlands.
Carmen OrellanaUnidad de Genética, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
Deb K PalDepartment of Basic & Clinical Neurosciences, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom.
Rafał PłoskiDepartment of Medical Genetics, Medical University of Warsaw, Warsaw, Poland.
Oliver W QuarrellDepartment of Clinical Genetics, Sheffield Children's NHS Foundation Trust, Sheffield, United Kingdom.
Monica RoselloUnidad de Genética, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
Małgorzata RydzaniczDepartment of Medical Genetics, Medical University of Warsaw, Warsaw, Poland.
Ataf SabirWest Midlands Clinical Genetics Unit, Birmingham Women's and Children's NHS FT and Birmingham Health Partners, Birmingham, United Kingdom.
Robert ŚmigielDivision Pediatric Propedeutics and Rare Disorders, Department of Pediatrics, Wroclaw Medical University, Wrocław, Poland.
Alexander P A StegmannDepartment of Clinical Genetics, Maastricht University Medical Centre, Maastricht, The Netherlands.
Helen StewartOxford Centre for Genomic Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
Constance StumpelDepartment of Clinical Genetics, Maastricht University Medical Centre, Maastricht, The Netherlands.
Elżbieta SzczepanikClinic of Pediatric Neurology, Institute of Mother and Child, Warsaw, Poland.
Andreas TzschachInstitute of Human Genetics, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Lynne WolfeNational Human Genome Research Institute, National Institutes of Health, Bethesda, MD.
Jenny C TaylorNIHR Oxford Biomedical Research Centre, Wellcome Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.
Yoshiko MurakamiYabumoto Department of Intractable Disease Research, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan; World Premier International Immunology Frontier Research Center, Osaka University, Osaka, Japan.
Taroh KinoshitaYabumoto Department of Intractable Disease Research, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan; World Premier International Immunology Frontier Research Center, Osaka University, Osaka, Japan.
Allan BayatDepartment of Epilepsy Genetics and Personalized Medicine, Danish Epilepsy Center, Dianalund, Denmark; Institute for Regional Health Services, University of Southern Denmark, Odense, Denmark.
Usha KiniOxford Centre for Genomic Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom. Electronic address: Usha.Kini@ouh.nhs.uk.
Hospital Universitari i Politècnic La Fe · ESGenetikum · DECentre for Human Genetics · GBMaastricht University Medical Centre · NLBirmingham Women’s and Children’s NHS Foundation Trust · GBHospices Civils de Lyon · FRInstitute of Psychiatry and Neurology · PLMedical University of Warsaw · PLNational Institutes of Health · USOsaka International University · JPOxford University Hospitals NHS Trust · GBUniversity Hospital Bonn · DEChildren's Health Ireland at Crumlin · IEDüsseldorf University Hospital · DEKing's College London · GBLeipzig University · DEOxford Health NHS Foundation Trust · GBSheffield Children's NHS Foundation Trust · GBSt Mary's Hospital · GBUniversity of Freiburg · DE

Funding

Human Biochemical GeneticsZIAHG000215 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI GAHL, WILLIAM · 2009 to 2025
$72.6M
Department of HealthIntramural NIH HHS Z99 HD999999Wellcome Trust
6 · The paper itself

Abstract

purposeBiallelic PIGN variants have been described in Fryns syndrome, multiple congenital anomalies-hypotonia-seizure syndrome (MCAHS), and neurologic phenotypes. The full spectrum of clinical manifestations in relation to the genotypes is yet to be reported.

methodsGenotype and phenotype data were collated and analyzed for 61 biallelic PIGN cases: 21 new and 40 previously published cases. Functional analysis was performed for 2 recurrent variants (c.2679C>G p.Ser893Arg and c.932T>G p.Leu311Trp).

resultsBiallelic-truncating variants were detected in 16 patients-10 with Fryns syndrome, 1 with MCAHS1, 2 with Fryns syndrome/MCAHS1, and 3 with neurologic phenotype. There was an increased risk of prenatal or neonatal death within this group (6 deaths were in utero or within 2 months of life; 6 pregnancies were terminated). Incidence of polyhydramnios, congenital anomalies (eg, diaphragmatic hernia), and dysmorphism was significantly increased. Biallelic missense or mixed genotype were reported in the remaining 45 cases-32 showed a neurologic phenotype and 12 had MCAHS1. No cases of diaphragmatic hernia or abdominal wall defects were seen in this group except patient 1 in which we found the missense variant p.Ser893Arg to result in functionally null alleles, suggesting the possibility of an undescribed functionally important region in the final exon. For all genotypes, there was complete penetrance for developmental delay and near-complete penetrance for seizures and hypotonia in patients surviving the neonatal period.

conclusionWe have expanded the described spectrum of phenotypes and natural history associated with biallelic PIGN variants. Our study shows that biallelic-truncating variants usually result in the more severe Fryns syndrome phenotype, but neurologic problems, such as developmental delay, seizures, and hypotonia, present across all genotypes. Functional analysis should be considered when the genotypes do not correlate with the predicted phenotype because there may be other functionally important regions in PIGN that are yet to be discovered.

Indexed as

Abnormalities, MultipleCongenital Disorders of GlycosylationEpilepsyHernia, DiaphragmaticFaciesFemaleGenetic Association StudiesHumansLimb Deformities, CongenitalMuscle HypotoniaPhenotypePregnancySeizuresSyndromeEpilepsyFryns syndromeGPI deficiencyMCAHS1PIGN

Identifiers

PMID36322149
PMCPMC11790076
OpenAlexW4307970836

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.